These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1150 related items for PubMed ID: 1376345

  • 21. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.
    MacGlashan DW, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie-White J, Sterbinsky SA, Hamilton RG, Lichtenstein LM.
    J Immunol; 1997 Feb 01; 158(3):1438-45. PubMed ID: 9013989
    [Abstract] [Full Text] [Related]

  • 22. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells.
    Patella V, Bouvet JP, Marone G.
    J Immunol; 1993 Nov 15; 151(10):5685-98. PubMed ID: 7693815
    [Abstract] [Full Text] [Related]

  • 23. Monoclonal antibodies specific to the alpha-subunit of the mast cell's Fc epsilon R block IgE binding and trigger histamine release.
    Baniyash M, Alkalay I, Eshhar Z.
    J Immunol; 1987 May 01; 138(9):2999-3004. PubMed ID: 2437203
    [Abstract] [Full Text] [Related]

  • 24. Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis.
    Sherr E, Macy E, Kimata H, Gilly M, Saxon A.
    J Immunol; 1989 Jan 15; 142(2):481-9. PubMed ID: 2521348
    [Abstract] [Full Text] [Related]

  • 25. Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo.
    Saini SS, MacGlashan DW, Sterbinsky SA, Togias A, Adelman DC, Lichtenstein LM, Bochner BS.
    J Immunol; 1999 May 01; 162(9):5624-30. PubMed ID: 10228046
    [Abstract] [Full Text] [Related]

  • 26. Bimodal IgG4-mediated human basophil activation. Role of eosinophils.
    Beauvais F, Hieblot C, Burtin C, Benveniste J.
    J Immunol; 1990 May 15; 144(10):3881-90. PubMed ID: 1692064
    [Abstract] [Full Text] [Related]

  • 27. Qualitative characteristics of histamine release from human basophils by covalently cross-linked IgE.
    Kagey-Sobotka A, Dembo M, Goldstein B, Metzger H, Lichtenstein LM.
    J Immunol; 1981 Dec 15; 127(6):2285-91. PubMed ID: 6170694
    [Abstract] [Full Text] [Related]

  • 28. [Correlation between serum IgE level and human basophil degranulation by anti-IgE antibodies].
    Chabane MH, Leynadier F, Lochak C, Nassar A, Dry J.
    Ann Immunol (Paris); 1983 Dec 15; 134C(3):355-64. PubMed ID: 6194737
    [Abstract] [Full Text] [Related]

  • 29. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.
    Gascan H, Gauchat JF, Aversa G, Van Vlasselaer P, de Vries JE.
    J Immunol; 1991 Jul 01; 147(1):8-13. PubMed ID: 1711085
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The heterogeneity of human IgE exemplified by the passive transfer of D2O sensitivity.
    MacDonald SM, White JM, Kagey-Sobotka A, MacGlashan DW, Lichtenstein LM.
    Clin Exp Allergy; 1991 Jan 01; 21(1):133-8. PubMed ID: 1708690
    [Abstract] [Full Text] [Related]

  • 32. Degranulation of in vitro differentiated mast cells stimulated by two monoclonal IgE specificities.
    Rofolovitch M, Amira M, Ginsburg H.
    Eur J Immunol; 1987 Mar 01; 17(3):385-92. PubMed ID: 2436921
    [Abstract] [Full Text] [Related]

  • 33. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
    Tam SW, Demissie S, Thomas D, Daëron M.
    Allergy; 2004 Jul 01; 59(7):772-80. PubMed ID: 15180766
    [Abstract] [Full Text] [Related]

  • 34. Human IgE receptor alpha-chain IgG chimera blocks passive cutaneous anaphylaxis reaction in vivo.
    Haak-Frendscho M, Ridgway J, Shields R, Robbins K, Gorman C, Jardieu P.
    J Immunol; 1993 Jul 01; 151(1):351-8. PubMed ID: 7686940
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.